文献速递肺栓塞与肺血管病

靶向转化生长因子-β受体在肺动脉高压中的作用

Targeting transforming growth factor-β receptors in pulmonary hypertension.
PubMed 文献 · Eur Respir J · 2021-02-04

本文综述了转化生长因子-β(TGF-β)超家族中TGF-β-activin-nodal分支与BMP-GDF分支在肺动脉高压(PAH)发病中的作用。家族性/遗传性PAH或特发性PAH患者中存在这些通路的胚系杂合突变和/或组成性成员表达改变,两分支间精细平衡的丧失或功能障碍被视为PAH易感性和疾病进展的关键分子缺陷。靶向TGF-β-activin-nodal分支可能为PAH提供新的治疗途径。

要点

  • TGF-β超家族分TGF-β-activin-nodal与BMP-GDF两分支,经Smad与非Smad通路发挥多样细胞效应。
  • 两分支间cross-talk调控细胞增殖、分化及组织发育维持,其失衡与PAH易感和进展相关。
  • PAH患者可检出通路相关胚系杂合突变或组成性成员表达改变,靶向该分支或为新型治疗方向。

核心结论

  • TGF-β-activin-nodal分支与BMP-GDF分支间精细平衡的丧失或功能障碍被认为是PAH易感性和疾病进展的关键分子缺陷。
  • 阐明TGF-β-activin-nodal分支在PAH中的作用为理解发病机制和探索新型治疗策略提供了依据。

研究设计与样本

  • 本文为综述,汇总近年关于TGF-β超家族两分支信号cross-talk及其在PAH中作用的数据。

主要发现

  • TGF-β超家族包括TGF-β-activin-nodal分支和BMP-GDF分支,分别经Smad2/3和Smad1/5/8等经典通路及非经典通路信号。
  • 两分支cross-talk参与细胞增殖与分化调控,以及不同组织器官发育和维持的信号转导。
  • 家族性/遗传性PAH或特发性PAH患者中存在通路相关胚系杂合突变和/或组成性成员表达改变。

临床怎么用

  • 可将TGF-β-activin-nodal分支与BMP-GDF分支的平衡作为理解PAH发病机制和评估治疗靶点的分子框架。

局限性

  • 本文为综述,未报告原始研究的设计细节、样本量或效应值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The transforming growth factor-β (TGF-β) superfamily includes several groups of multifunctional proteins that form two major branches, namely the TGF-β-activin-nodal branch and the bone morphogenetic protein (BMP)-growth differentiation factor (GDF) branch. The response to the activation of these two branches, acting through canonical (small mothers against decapentaplegic (Smad) 2/3 and Smad 1/5/8, respectively) and noncanonical signalling pathways, are diverse and vary for different environmental conditions and cell types. An extensive body of data gathered in recent years has demonstrated a central role for the cross-talk between these two branches in a number of cellular processes, which include the regulation of cell proliferation and differentiation, as well as the transduction of signalling cascades for the development and maintenance of different tissues and organs. Importantly, alterations in these pathways, which include heterozygous germline mutations and/or alterations in the expression of several constitutive members, have been identified in patients with familial/heritable pulmonary arterial hypertension (PAH) or idiopathic PAH (IPAH). Consequently, loss or dysfunction in the delicate, finely-tuned balance between the TGF-β-activin-nodal branch and the BMP-GDF branch are currently viewed as the major molecular defect playing a critical role in PAH predisposition and disease progression. Here we review the role of the TGF-β-activin-nodal branch in PAH and illustrate how this knowledge has not only provided insight into understanding its pathogenesis, but has also paved the way for possible novel therapeutic approaches.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Guignabert C, Humbert M. Targeting transforming growth factor-β receptors in pulmonary hypertension. Eur Respir J. 2021. PMID: 32817256. doi:10.1183/13993003.02341-2020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。